Modification of PLAC8 by UFM1 affects tumorous proliferation and immune response by impacting PD-L1 levels in triple-negative breast cancer

BACKGROUND: Triple-negative breast cancer is characterized by a poor prognosis and lack of targeted treatments, and thus, new targeting markers and therapeutic strategies are urgently needed. We previously indicated that PLAC8 promotes tumorigenesis and exerts multidrug resistance in breast cancer....

Descripción completa

Detalles Bibliográficos
Autores principales: Mao, Misha, Chen, Yongxia, Yang, Jingjing, Cheng, Yifan, Xu, Ling, Ji, Feiyang, Zhou, Jichun, Zhang, Xun, Li, Zhaoqing, Chen, Cong, Ju, Siwei, Zhang, Jiahang, Wang, Linbo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2022
Materias:
Immunotherapy Biomarkers
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9772693/
https://www.ncbi.nlm.nih.gov/pubmed/36543379
http://dx.doi.org/10.1136/jitc-2022-005668

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9772693/
https://www.ncbi.nlm.nih.gov/pubmed/36543379
http://dx.doi.org/10.1136/jitc-2022-005668

Ejemplares similares